Advertisement
Syngene International Ltd.
Premium
Healthcare
25 September, 2023
TPG-backed firm to absorb Indian drugmaker's contract development biz, go public
An Indian biopharmaceutical company that counts private equity firm TPG as an investor will absorb a local drugmaker’s contract development ......
Premium
Healthcare
24 July, 2023
Advent may rope in new investor for Bharat Serums with neat valuation markup
Mumbai-based biopharmaceutical company Bharat Serums, controlled by private equity major Advent International, is looking to onboard new investor(s) for a ......
Premium
Healthcare
11 September, 2017
Temasek bets on another Indian healthcare company
Singapore state investment firm Temasek Holdings has picked up a minority stake in an Indian drug research company, thereby increasing ......
Premium
Healthcare
18 May, 2017
True North makes partial exit from drug research firm with strong gains
Private equity firm True North has sold a bulk of its stake in a drug research company, harvesting handsome gains ......
Premium
Healthcare
19 August, 2014
Biocon subsidiary Syngene International looking to raise over $50M
Syngene International, a subsidiary of Biocon Ltd, a generics major that also owns the country's largest drug research and development ......
Advertisement
Recommended for you
Advertisement